[1]王涛*,赵倩,侯倩男,等.内脂素在妊娠期糖尿病患者中的检测价值[J].中国计划生育和妇产科,2017,(3):65- 67,78.
　WANG Tao*,ZHAO Qian,HOU Qian-nan,et al.The detective value of serum visfatin in patients with gestational diabetes mellitus[J].Chinese Journal of Family Planning & Gynecotokology,2017,(3):65- 67,78.
点击复制

内脂素在妊娠期糖尿病患者中的检测价值
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2017年3期
页码:
65- 67,78
栏目:
论著与临床
出版日期:
2017-03-25

文章信息/Info

Title:
The detective value of serum visfatin in patients with gestational diabetes mellitus
作者:
王涛*; 赵倩; 侯倩男; 冯丹
成都妇女儿童中心医院产科
Author(s):
WANG Tao*; ZHAO Qian; HOU Qian-nan; FENG Dan
Department of Obstetrics，Chengdu Women and Children’s Central Hospital，Chengdu Sichuan 610099，P.R.China
关键词:
内脂素; 妊娠期糖尿病; 胰岛素抵抗; 孕妇
Keywords:
visfatin;  gestational diabetes mellitus;  insulin resisitance; pregnant woman
分类号:
R 714.256
摘要:
目的探讨血清内脂素（visfatin, VF）在妊娠期糖尿病（gestational diabetes mellitus, GDM）中的临床意义及其与胰岛素抵抗（insulin resistance, IR）的关系。方法分析2015年5月至2016年5月在成都市妇女儿童中心医院接受产前检查且住院分娩的GDM孕妇（38例，观察组）和正常孕妇（38例，对照组）的临床资料，比较两组孕妇基础临床指标水平、糖尿病家族史、血清VF、空腹血糖（fasting plasma glucose, FPG）、空腹胰岛素（fasting insulin, FINS）及胰岛素抵抗指数（insulin resistance index, IRI）水平，分析两组孕妇血清VF与相关因素的关系。结果两组孕妇的孕周、身高、孕前体重及体质量指数（body mass index, BMI）、糖尿病家族史差异均无统计学意义（P>005）；观察组孕妇诊断时的体重及BMI值、血清VF、FPG、FINS及IRI水平均明显高于对照组（P<005）。两组孕妇的血清VF水平与其孕前体重及BMI、诊断时体重及BMI、FPG均无相关性，但与FINS及IRI呈显著正相关（P<005）。结论血清VF在GDM孕妇的发病中发挥着重要的作用，其与IR有正相关性。
Abstract:
ObjectiveTo analyze the clinical value of serum visfatin（VF） in pregnant women with gestational diabetes mellitus(GDM) and the relationship between VF and insulin resistance. MethodsClinical data of 38 pregnant women with GDM(observation group) and 38 normal pregnant women(control group) received prenatal examination and hospital delivery in Chengdu Women and Children’s Central Hospital from May 2015 to May 2016 was retrospectively analyzed. The levels of basic clinical indicators, family history of diabetes, serum levels of VF, fasting plasma glucose（FPG）, fasting insulin（FINS） and insulin resistance index（IRI）of the two groups were compared. Relationship between serum VF and related factors of the two groups was analyzed. ResultsThe gestational weeks, height, pre-gestational weight,body mass index（BMI）and family history of diabetes in the two groups had no statistical difference(P>005). The weight and BMI at the time of diagnosis，serum levels of VF, FPG, FINS and IRI in the observation group were obviously higher than those in the control group(P<005). Serum levels of VF had no correlation with pre-gestational weight and BMI, the weight and BMI at the time of diagnosis, as well as FPG in the two groups, but had positive correlation with FINS and IRI(P<005). ConclusionSerum VF plays an important role in the process of GDM. The level of serum VF has positive correlation with insulin resisitance.

参考文献/References:

［1］BAO Wei, BAECKER A, SONG Yi-qing, et al. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: A systematic review ［J］. Metabolism-Clinical and Experimental, 2015, 64 (6) : 756-764. ［2］MA Yao, CHENG Yan, WANG Jue, et al. The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes ［J］. Diabetes Research and Clinical Practice, 2010, 90 (1) : 60-65. ［3］FERREIRA A F, REZENDE J C, VAIKOUSI E, et al. Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus ［J］. Clinical Chemistry, 2011, 57 (4) : 609-613. ［4］MIEHLE K, STEPAN H, FASSHAUER M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia ［J］. Clinical Endocrinology, 2012, 76 (1) : 2-11. ［5］LIANG Zhaoxia, WU Ying, CHEN Dan-qing. Changes in visfatin levels after oral glucose tolerance test in women with gestational diabetes mellitus ［J］. Diabetes Research and Clinical Practice, 2012, 96 (3) : e76-e79. ［6］PARK S, KIM M Y, BAIK S H, et al. Gestational diabetes is associated with high energy and saturated fat intakes and with low plasma visfatin and adiponectin levels Independent of prepregnancy BMI ［J］. European Journal of Clinical Nutrition, 2013, 67 (2) : 196-201. ［7］LAPPAS M, JINKS D, UGONI A, et al. Post-partum plasma C-peptide and ghrelin concentrations are predictive of type 2 diabetes in women with previous gestational diabetes mellitus ［J］. Journal of Diabetes, 2015, 7 (4) : 506-511. ［8］LIANG Zhaoxia, WU Ying, XU Jianyun, et al. Correlations of serum visfatin and metabolisms of glucose and lipid in women with gestational diabetes mellitus ［J］. Journal of Diabetes Investigation, 2016, 7 (2) : 247-252. ［9］GOK D E, YAZICI M, UCKAYA G, et al. The role of visfatin in the pathogenesis of gestational diabetes mellitus ［J］. Journal of Endocrinological Investigation, 2011, 34 (1) : 3-7. ［10］SKVARCA A, TOMAZIC M, KRHIN B, et al. Adipocytokines and insulin resistance across various degrees of glucose tolerance in pregnancy ［J］. The Journal of International Medical Research, 2012, 40 (2) : 583-589. ［11］ONCUL M, TUTEN A, ERMAN H, et al. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus ［J］. Minerva Medica, 2013, 104(5): 527-535. ［12］Luo JX, Liu XH, Zhang L，et al. The expression of visfatin in placenta in women with gestational diabetes mellitus ［J］. Sichuan Da Xue Xue Bao Yi Xue Ban, 2011，42 (2) : 204-207

相似文献/References:

[1]程兰.妊娠期糖代谢异常患者血清胱抑素C测定的意义[J].中国计划生育和妇产科,2010,(06):0.
　CHENG Lan Tianjin Centtal Gynaecology and Obstetrics Hospital of,Tianjin 0000,China.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(3):0.
[2]赵昆.D-二聚体测定在产科常见病理性高凝状态疾病的临床意义[J].中国计划生育和妇产科,2011,(04):0.
　ZHAO Kun.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(3):0.
[3]潘玥,刘巧,朱绍密,等.妊娠期糖尿病胰岛素治疗的临床分析[J].中国计划生育和妇产科,2011,(06):0.
　PAN Yue,LIU Qiao,ZHU Shao-mi.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(3):0.
[4]黎凤彩,苏凌春,曾志娟,等.血清胱抑素C联合血清尿酸在监测妊娠期糖尿病发生妊娠期高血压疾病的临床意义[J].中国计划生育和妇产科,2013,(05):0.
　LI Feng-cai,SU Ling-chun,ZENG Zhi-juan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(3):0.
[5]王国育.妊娠期糖尿病孕妇孕前体质量指数对分娩方式和新生儿体质量的影响[J].中国计划生育和妇产科,2014,(07):0.
　WANG Guo-yu,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(3):0.
[6]赵卓姝,关海兰,何洁云,等.孕期个性化营养指导对妊娠期糖尿病患者妊娠结局的影响[J].中国计划生育和妇产科,2014,(08):0.
　ZHAO Zhuo-shu,GUAN Hai-lan,HE Jie-yun,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(3):0.
[7]徐辉,姜群英,韦红梅,等.个性化营养干预对妊娠期糖尿病的治疗作用[J].中国计划生育和妇产科,2015,(01):0.
　XU Hui,JIANG Qun-ying,WEI Hong-mei,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(3):0.
[8]孙桢,黄立,夏勇,等.妊娠期糖尿病与核转录因子NF-κBp65相关性研究[J].中国计划生育和妇产科,2015,(04):0.
　SUN Zhen,HUANG Li,XIA Yong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(3):0.
[9]杨立黔.妊娠期糖尿病诊断新标准对母婴结局的影响[J].中国计划生育和妇产科,2015,(07):0.
　YANG Li-qian,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(3):0.
[10]杨金英,钟利若,刘晓英,等.小麦纤维素对妊娠期糖尿病患者血糖和血脂的影响研究[J].中国计划生育和妇产科,2015,(10):0.
　YANG Jin-ying,ZHONG Li-ruo,LIU Xiao-ying,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(3):0.

更新日期/Last Update: 2017-03-25